OSGIN2: A Potential Drug Target and Biomarker for Oxidative Stress-Induced Growth Inhibition

Target Name: OSGIN2

NCBI ID: G734

OSGIN2

OSGIN2: A Potential Drug Target and Biomarker for Oxidative Stress-Induced Growth Inhibition

Oxidative stress-induced growth inhibition (OSIGI) is a well-established mechanism of cellular growth regulation, in which cellular responses to oxidative stress lead to a temporary increase in p53-mediated DNA damage and subsequent inhibition of cell growth. OSIGI is a critical pathway that regulates cellular growth and has implications for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The identification of potential drug targets and biomarkers for OSIGI has the potential to lead to new therapeutic approaches for these diseases.

OSGIN2: A Potential Drug Target

The OSGIN2 gene was identified as a potential drug target for OSIGI by its expression in various tissues and cell types under oxidative stress conditions. OSGIN2 has been shown to play a critical role in the regulation of cellular growth and cell cycle progression under oxidative stress conditions.

The OSGIN2 protein

OSGIN2 is a 21-kDa protein that is expressed in various tissues and cell types, including brain, heart, liver, and muscle. It is a member of the TG/XP family, which includes other proteins involved in cell cycle regulation, such as p21 and p53. OSGIN2 has been shown to play a role in the regulation of cellular growth and cell cycle progression by inhibiting the activity of the transcription factor, p21 (TISF2), which is involved in the regulation of cell cycle progression and apoptosis.

In addition to its role in cell cycle regulation, OSGIN2 has also been shown to play a critical role in the regulation of cellular stress responses. It has been shown to interact with the stress-responsive protein, p53, and to participate in the regulation of DNA damage repair under oxidative stress conditions.

OSGIN2 as a potential drug target

The identification of OSGIN2 as a potential drug target for OSIGI has implications for the development of new therapeutic approaches for various diseases. OSGIN2 has been shown to play a critical role in the regulation of cellular growth and cell cycle progression, as well as cellular stress responses. Therefore, targeting OSGIN2 with small molecules or other therapeutic agents may be a promising approach for the treatment of diseases that are characterized by oxidative stress-induced growth inhibition.

Conclusion

OSGIN2 is a potential drug target for OSIGI that has been shown to play a critical role in the regulation of cellular growth and cell cycle progression under oxidative stress conditions. Further research is needed to fully understand the role of OSGIN2 in the regulation of cellular stress responses and to identify effective small molecules or other therapeutic agents that can be used to target OSGIN2 in the treatment of OSIGI-related diseases.

Protein Name: Oxidative Stress Induced Growth Inhibitor Family Member 2

Functions: May be involved in meiosis or the maturation of germ cells

The "OSGIN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSGIN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets